Drug Trial Radar · NCT04573803
Pharmacological Management of Seizures Post Traumatic Brain Injury
Last checked: Nov 19, 2026Latest source record: Nov 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,649
Planned (sponsor's estimate)
Start
Mar 1, 2021
Primary completion
Mar 1, 2026
Study completion Mar 1, 2028
Sponsor
- Lead sponsor
- Cambridge University Hospitals NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Cambridge
- First posted
- Oct 5, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall aim of the MAST trial is to define best practice in the use of anti-epileptic drugs (AEDs) for patients following a traumatic brain injury (TBI). The trial will consist of two parts. The first part aims to answer whether a shorter or a longer course of AEDs is better to prevent further seizures in patients who have started having seizures following TBI (MAST - duration). The second part aims to answer whether a 7-day course of either Phenytoin or Levetiracetam should be used for patients with a serious TBI to prevent seizures from starting (MAST- prophylaxis).
Conditions
- Traumatic Brain Injury
- Post Traumatic Seizures
Interventions
Phenytoin SodiumDrug
Dosing will be as prescribed clinically by the treating physician. Phenytoin Sodium may be administered orally, intravenously or via nasogastric tube.
LevetiracetamDrug
Dosing will be as prescribed clinically by the treating physician.Levetiracetam may be administered orally, intravenously or via nasogastric tube.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MAST-DURATION: Occurrence of late PTSTime frame: Within 24 months post traumatic brain injury
- MAST-PROPHYLAXIS: Occurrence of PTSTime frame: Within 2 weeks post TBI
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.